ARVN - Arvinas Inc
IEX Last Trade
26.13
0.090 0.344%
Share volume: 339,704
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$26.04
0.09
0.35%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-02-23 | 2023-05-05 | 2023-08-08 | 2023-11-07 | 2024-02-27 | 2024-05-07 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 1.335 B | 1.269 B | 1.176 B | 1.084 B | 1.058 B | 1.305 B | 1.213 B | 1.280 B | |
| Current Assets | 1.305 B | 1.240 B | 1.148 B | 1.057 B | 1.033 B | 1.280 B | 1.190 B | 1.257 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 21.700 M | 21.400 M | 14.500 M | 7.600 M | 8.400 M | 6.500 M | 8.400 M | 12.500 M | |
| Short Term Investments | 21.700 M | 21.400 M | 14.500 M | 7.600 M | 8.400 M | 6.500 M | 8.400 M | 12.500 M | |
| Total Receivables | 6.800 M | 8.000 M | 4.700 M | 4.800 M | 20.600 M | 7.200 M | 7.100 M | 10.000 M | |
| Current Cash | 1.271 B | 1.205 B | 1.124 B | 1.039 B | 998.500 M | 1.261 B | 1.169 B | 1.229 B | |
| Total Non-current Assets | 30.100 M | 28.600 M | 27.600 M | 26.800 M | 25.300 M | 24.400 M | 22.300 M | 22.900 M | |
| Property Plant Equipment | 14.000 M | 13.400 M | 13.400 M | 13.200 M | 12.700 M | 11.500 M | 10.400 M | 9.800 M | |
| Other Assets | 16.100 M | 15.200 M | 14.200 M | 13.600 M | 12.600 M | 12.900 M | 11.900 M | 13.100 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.335 B | 1.269 B | 1.176 B | 1.084 B | 1.058 B | 1.305 B | 1.213 B | 1.280 B | |
| Total liabilities | 713.300 M | 703.900 M | 664.800 M | 619.900 M | 601.100 M | 644.600 M | 602.900 M | 679.400 M | |
| Total current liabilities | 244.600 M | 295.100 M | 282.900 M | 306.900 M | 317.300 M | 257.100 M | 240.800 M | 347.200 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 464.600 M | 405.100 M | 378.900 M | 310.500 M | 281.900 M | 386.200 M | 361.000 M | 331.300 M | |
| Current long term debt | 1.800 M | 1.800 M | 2.000 M | 2.000 M | 2.100 M | 1.900 M | 1.500 M | 1.200 M | |
| Long term debt | 4.100 M | 3.700 M | 3.000 M | 2.500 M | 1.900 M | 1.300 M | 1.100 M | 900.000 K | |
| Other liabilities | 464.600 M | 405.100 M | 378.900 M | 310.500 M | 281.900 M | 386.200 M | 361.000 M | 331.300 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 621.500 M | 564.900 M | 511.000 M | 463.600 M | 457.200 M | 660.000 M | 609.700 M | 600.200 M | |
| Common stock | 53.200 M | 53.400 M | 53.300 M | 53.400 M | 54.100 M | 61.200 M | 71.700 M | 71.900 M | |
| Retained earnings | -882.500 M | -965.400 M | -1.047 B | -1.114 B | -1.178 B | -1.333 B | -1.402 B | -1.437 B |